Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $713.8900 (0.5%) ($713.8900 - $713.8900) on Wed. Dec. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.64% (three month average) | RSI | 26 | Latest Price | $713.8900(0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) DIA(32%) IWD(28%) SPLV(28%) IVW(26%) | Factors Impacting REGN price | REGN will decline at least -0.82% in a week (0% probabilities). TBT(-13%) EDOC(-7%) URA(-6%) VCSH(-5%) ARKG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.82% (StdDev 1.64%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $740.44 | 5 Day Moving Average | $723.41(-1.32%) | 10 Day Moving Average | $726.83(-1.78%) | 20 Day Moving Average | $740.44(-3.59%) | To recent high | -6.8% | To recent low | 3.6% | Market Cap | $75.693b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |